Hyper-IgE syndromes in pediatrics: clinical spectrum, differential diagnosis, and management
Folia Medica · 13.08.2026 · 68 (4)
DOI: 10.3897/folmed.68.e173262 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Folia Medica, online erschienen am 13.08.2026. Verfasst von Svjetlana Mikulić und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina. Hauptthemen laut MEDLINE: Job Syndrome. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hyper-IgE syndromes (HIES) are rare inborn errors of immunity (≈1 per million) caused by pathogenic variants in STAT3, DOCK8 or IL6ST. They present with very high serum immunoglobulin E (IgE), recurrent bacterial or fungal infections, eczema and characteristic organ involvement. The autosomal dominant STAT3-deficient form features early-onset eczema, “cold” abscesses, recurrent pneumonias with pneumatoceles and skeletal or dental anomalies. Autosomal recessive forms such as DOCK8 or PGM3 deficiency show a more severe phenotype with viral skin infections, allergy, asthma and increased malignancy risk. HIES should be suspected in children with IgE >2000 IU/mL plus recurrent sinopulmonary or skin infections, severe eczema, atypical viral infections or a National Institutes of Health Hyper-IgE Syndrome (NIH HIES) score >40. Differentiation from severe atopic dermatitis, asthma, eosinophilic disorders and parasitic infections is essential. Evaluation includes eosinophils, lymphocyte subsets, T-helper 17 (Th17) cell analysis and targeted genetic testing. Management involves antimicrobial prophylaxis, treatment of complications, dermatologic care and genotype-based hematopoietic stem cell transplantation (HSCT), which is curative in DOCK8 but less effective in STAT3 deficiency. Early genomic confirmation enables timely recognition, identification of red flags, and genotype-specific therapy to improve long-term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina.
- Specialist Family Medicine Practice Dr. Mila Vasilj Mihaljević, Vukovar, Croatia.
ORCID-Profile: Svjetlana Mikulić, Daniela Kraljević
Zitieren
APA
Mikulić, S., Mihaljević, M. V., & Kraljević, D. (2026). Hyper-IgE syndromes in pediatrics: clinical spectrum, differential diagnosis, and management. Folia Medica, 68(4). https://doi.org/10.3897/folmed.68.e173262
Vancouver
Mikulić S, Mihaljević MV, Kraljević D. Hyper-IgE syndromes in pediatrics: clinical spectrum, differential diagnosis, and management. Folia Medica. 2026;68(4). doi:10.3897/folmed.68.e173262
BibTeX
@article{Mikuli2026,
author = {Mikulić, Svjetlana and Mihaljević, Mila Vasilj and Kraljević, Daniela},
title = {Hyper-IgE syndromes in pediatrics: clinical spectrum, differential diagnosis, and management},
journal = {Folia Medica},
year = {2026},
volume = {68},
number = {4},
doi = {10.3897/folmed.68.e173262}
}
EUVIMED